William J. Newman, MD

New-onset psychosis while being treated for coronavirus

While receiving treatment for COVID-19, Mr. G, age 56, experiences an acute psychotic episode. He has no known psychiatric history. What could be...

FINAL OF 3 PARTS Clozapine has been available for decades, but relatively little has been published regarding its off-label uses. This data...

Benefit comes at the expense of monitoring for, and treating, an array of potential problems. Second of 3 parts.

William J. Newman, MD, and Brianne M. Newman, MD, provide a glimpse of their 3-part series on the use of clozapine, which appears in the July,...

FDA’s overhaul of management guidelines is good reason to get reacquainted. First of 3 parts.

Mr. K, age 42, who has a history of schizophrenia, arrives at the emergency room agitated and belligerent. Physical exam reveals type 2 diabetes...